新加良附颗粒配合化疗治疗进展期胃癌临床研究
目的观察新加良附颗粒配合化疗治疗进展期胃癌的临床疗效。方法采用前瞻性随机对照多中心的临床试验方法，并通过中央（网上）随机法将符合Ⅲ／Ⅳ期胃癌患者42例随机分为对照组、治疗组，治疗组选择标准化疗方案配合新加良附颗粒治疗，对照组单纯接受化疗，治疗过程中2组均同时给予最佳对症支持治疗，分别观察4个化疗周期，在入组当天及各周期末记录症状与体征记分、卡氏评分、疼痛数字评分法评分、病灶大小、血尿常规、肝肾功能、心电图等指标。结果新加良附颗粒配合化疗组21例，单纯化疗组20例，脱落1例，研究结果显示：①治疗组在临床症状与体征的改善方面明显优于对照组，具有统计学意义，P〈0．005。治疗组对胃脘疼痛、胸腹胀满...
Saved in:
| Published in | 北京中医药大学学报 Vol. 40; no. 7; pp. 593 - 598 |
|---|---|
| Main Author | |
| Format | Journal Article |
| Language | Chinese |
| Published |
北京中医药大学东直门医院 北京100700%广州中医药大学
2017
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 1006-2157 |
| DOI | 10.3969/j.issn.1006-2157.2017.07.011 |
Cover
| Abstract | 目的观察新加良附颗粒配合化疗治疗进展期胃癌的临床疗效。方法采用前瞻性随机对照多中心的临床试验方法，并通过中央（网上）随机法将符合Ⅲ／Ⅳ期胃癌患者42例随机分为对照组、治疗组，治疗组选择标准化疗方案配合新加良附颗粒治疗，对照组单纯接受化疗，治疗过程中2组均同时给予最佳对症支持治疗，分别观察4个化疗周期，在入组当天及各周期末记录症状与体征记分、卡氏评分、疼痛数字评分法评分、病灶大小、血尿常规、肝肾功能、心电图等指标。结果新加良附颗粒配合化疗组21例，单纯化疗组20例，脱落1例，研究结果显示：①治疗组在临床症状与体征的改善方面明显优于对照组，具有统计学意义，P〈0．005。治疗组对胃脘疼痛、胸腹胀满、畏寒肢冷、食欲不振等症状有改善作用，具有统计学意义，P〈0．05。②治疗组总体健康状况的改善明显优于对照组，具有统计学意义，P〈0．05。③治疗组较对照组虽有更高的临床缓解率，但无统计学意义，P〉0．05。（4）新加良附颗粒在临床应用过程中，具有良好的安全性。结论新加良附颗粒具有改善进展期胃癌患者临床症状，提高患者生活质量，减轻化疗毒副反应等作用，临床应用安全有效。 |
|---|---|
| AbstractList | 目的观察新加良附颗粒配合化疗治疗进展期胃癌的临床疗效。方法采用前瞻性随机对照多中心的临床试验方法，并通过中央（网上）随机法将符合Ⅲ／Ⅳ期胃癌患者42例随机分为对照组、治疗组，治疗组选择标准化疗方案配合新加良附颗粒治疗，对照组单纯接受化疗，治疗过程中2组均同时给予最佳对症支持治疗，分别观察4个化疗周期，在入组当天及各周期末记录症状与体征记分、卡氏评分、疼痛数字评分法评分、病灶大小、血尿常规、肝肾功能、心电图等指标。结果新加良附颗粒配合化疗组21例，单纯化疗组20例，脱落1例，研究结果显示：①治疗组在临床症状与体征的改善方面明显优于对照组，具有统计学意义，P〈0．005。治疗组对胃脘疼痛、胸腹胀满、畏寒肢冷、食欲不振等症状有改善作用，具有统计学意义，P〈0．05。②治疗组总体健康状况的改善明显优于对照组，具有统计学意义，P〈0．05。③治疗组较对照组虽有更高的临床缓解率，但无统计学意义，P〉0．05。（4）新加良附颗粒在临床应用过程中，具有良好的安全性。结论新加良附颗粒具有改善进展期胃癌患者临床症状，提高患者生活质量，减轻化疗毒副反应等作用，临床应用安全有效。 R273; 目的 观察新加良附颗粒配合化疗治疗进展期胃癌的临床疗效.方法 采用前瞻性随机对照多中心的临床试验方法,并通过中央(网上)随机法将符合Ⅲ/Ⅳ期胃癌患者42例随机分为对照组、治疗组,治疗组选择标准化疗方案配合新加良附颗粒治疗,对照组单纯接受化疗,治疗过程中2组均同时给予最佳对症支持治疗,分别观察4个化疗周期,在入组当天及各周期末记录症状与体征记分、卡氏评分、疼痛数字评分法评分、病灶大小、血尿常规、肝肾功能、心电图等指标.结果 新加良附颗粒配合化疗组21例,单纯化疗组20例,脱落1例,研究结果显示:①治疗组在临床症状与体征的改善方面明显优于对照组,具有统计学意义,P＜0.005.治疗组对胃脘疼痛、胸腹胀满、畏寒肢冷、食欲不振等症状有改善作用,具有统计学意义,P ＜0.05.②治疗组总体健康状况的改善明显优于对照组,具有统计学意义,P ＜0.05.③治疗组较对照组虽有更高的临床缓解率,但无统计学意义,P ＞0.05.(4)新加良附颗粒在临床应用过程中,具有良好的安全性.结论 新加良附颗粒具有改善进展期胃癌患者临床症状,提高患者生活质量,减轻化疗毒副反应等作用,临床应用安全有效. |
| Abstract_FL | Objective To observe the clinical efficacy of Xinjia Liangfu (Modified Galangal and Cyperus) Granules on advanced gastric cancer.Methods The patients with stage Ⅲ/Ⅳ gastric cancer (n =42) were randomly divided into control group and treatment group by applying prospective randomized controlled multi-center clinical trial method.The treatment group was treated with standard chemotherapy regimens combined with Xinjia Liangfu Granules,and control group,with only chemotherapy regimens.During the therapeutic course,2 groups were given the best supportive care and observed for 4 cycles of chemotherapy.The scores of symptoms and signs,Karnofsky performance status (KPS),pain numerical rating scale,tumor size and indexes of blood and urine routine tests,liver and renal functions and electrocardiogram were recorded on the day of grouping and at the end of each cycle of chemotherapy.Results There were 21 cases in treatment group,20 in control group and 1 case was missed.The trial results showed that the relief of symptoms and signs was significant superior in treatment group to that in control group (P ＜ 0.005).The symptoms of stomach pain,abdominal distension and pain,fearing of cold,cold limbs and loss of appetite were relieved in treatment group (P ＜ 0.05).The improvement of total physical condition were superior in treatment group to that in control group (P ＜0.05).The treatment group had higher clinical remission rate compared with control group but the difference had no statistical significance (P ＞ 0.05).Xinjia Liangfu Granules had a higher safety in clinical administration.Conclusion Xinjia Liangfu Granules has the effects of relieving symptoms,improving quality of life and reducing toxic and side effects of chemotherapy,and it is safe and effective in clinic. |
| Author | 王婧 郭珊珊 侯丽 陈信义 田劭丹 |
| AuthorAffiliation | 北京中医药大学东直门医院,北京100700 广州中医药大学 |
| AuthorAffiliation_xml | – name: 北京中医药大学东直门医院 北京100700%广州中医药大学 |
| Author_FL | CHEN Xinyi HOU Li GUO Shanshan TIAN Shaodan WANG Jing |
| Author_FL_xml | – sequence: 1 fullname: WANG Jing – sequence: 2 fullname: GUO Shanshan – sequence: 3 fullname: HOU Li – sequence: 4 fullname: CHEN Xinyi – sequence: 5 fullname: TIAN Shaodan |
| Author_xml | – sequence: 1 fullname: 王婧 郭珊珊 侯丽 陈信义 田劭丹 |
| BookMark | eNo9j81Kw0AUhWdRwVr7EuJKSJyfZCazEin-QcFN92Uyk9QUnWqD2LqtgpYKItpSFCzuXKlFRHThy5imfQtHKsLlXDj341zOHMjomg4AWETQJpzy5aodxbG2EYTUwshlNoaI2dAMQhmQ_fdnQT6OIx8aGxIOeRasjLrPSXswPn-a9E8mD710eDU5vUguz5JON-32RsNPo-Ov2-TlZnR3P2610n7n-_01-Wing-v08W0ezIRiNw7yfzsHSutrpcKmVdze2CqsFi1JMbKUhMr1Q5dwSQgNuERKelLw0DFn4TDBXIYlClEQespVTBHhMaSopNDFlDkkB5amsUdCh0JXytXaYV2bh2W_etxsqkbD_60MmWlm4IUpLHdqunIQGXy_Hu2JerNMGfYIcTAhPyPAce4 |
| ClassificationCodes | R273 |
| ContentType | Journal Article |
| Copyright | Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
| Copyright_xml | – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
| DBID | 2RA 92L CQIGP W91 ~WA 2B. 4A8 92I 93N PSX TCJ |
| DOI | 10.3969/j.issn.1006-2157.2017.07.011 |
| DatabaseName | 维普期刊资源整合服务平台 中文科技期刊数据库-CALIS站点 维普中文期刊数据库 中文科技期刊数据库-医药卫生 中文科技期刊数据库- 镜像站点 Wanfang Data Journals - Hong Kong WANFANG Data Centre Wanfang Data Journals 万方数据期刊 - 香港版 China Online Journals (COJ) China Online Journals (COJ) |
| DatabaseTitleList | |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| DocumentTitleAlternate | Treatment of advanced gastric cancer with Xinjia Liangfu Granules combined with chemotherapy |
| DocumentTitle_FL | Treatment of advanced gastric cancer with Xinjia Liangfu Granules combined with chemotherapy |
| EndPage | 598 |
| ExternalDocumentID | bjzyydxxb201707011 672833423 |
| GrantInformation_xml | – fundername: 国家自然科学基金面上资助项目; 高等学校博士点新教师基金专项基金资助项目; 北京市科委科技计划重大资助项目; 北京中医药大学东直门医院2016青苗人才计划; National Natural Science Foundation of China; New Teacher Special Fund for Doctoral Program of Higher Education; Science and Technology Plan of Beijing Municipal Science and Technology Commission funderid: (81573959); (200800261007); (D131100002213002); 北京中医药大学东直门医院2016青苗人才计划; (81573959); (200800261007); (D131100002213002) |
| GroupedDBID | -05 23N 2B. 2C~ 2RA 5GY 92F 92I 92L ABDBF ACGFS ALMA_UNASSIGNED_HOLDINGS CCEZO CIEJG CQIGP CW9 EOJEC OBODZ TCJ TGQ U1G U5O W91 ~WA 4A8 93N ABJNI ACUHS PSX |
| ID | FETCH-LOGICAL-c621-dc0d5bf539c336e9c1dc8ca9f4c62a47a7572c1f1ef8d5d7d3a871d6c60526743 |
| ISSN | 1006-2157 |
| IngestDate | Thu May 29 04:06:59 EDT 2025 Wed Feb 14 09:59:17 EST 2024 |
| IsPeerReviewed | false |
| IsScholarly | true |
| Issue | 7 |
| Keywords | Xinjia Liangfu (Modified Galangal and Cyperus) Granules 新加良附颗粒 gastric cancer 进展期胃癌 临床研究 clinical studies 胃癌 advanced gastric cancer |
| Language | Chinese |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c621-dc0d5bf539c336e9c1dc8ca9f4c62a47a7572c1f1ef8d5d7d3a871d6c60526743 |
| Notes | clinical studies ; gastric cancer; Xinjia Liangfu （ Modified Galangal and Cyperus） Granules ; advanced gastric cancer 11-3574/R Objective To observe the clinical efficacy of Xinjia Liangfu （Modified Galangal and Cyperus） Granules on advanced gastric cancer. Methods The patients with stage Ⅲ/Ⅳ gastric cancer （n = 42 ） were randomly divided into control group and treatment group by applying prospective randomized controlled multi-center clinical trial method. The treatment group was treated with standard chemotherapy regimens combined with Xinjia Liangfu Granules, and control group, with only chemotherapy regimens. During the therapeutic course, 2 groups were given the best supportive care and observed for 4 cycles of chemotherapy. The scores of symptoms and signs, Kamofsky performance status （KPS）, pain numerical rating scale, tumor size and indexes of blood and urine routine tests, liver and renal functions and electrocardiogram were recorded on the day of grouping and at the end of each cycle of chemotherapy. |
| PageCount | 6 |
| ParticipantIDs | wanfang_journals_bjzyydxxb201707011 chongqing_primary_672833423 |
| PublicationCentury | 2000 |
| PublicationDate | 2017 |
| PublicationDateYYYYMMDD | 2017-01-01 |
| PublicationDate_xml | – year: 2017 text: 2017 |
| PublicationDecade | 2010 |
| PublicationTitle | 北京中医药大学学报 |
| PublicationTitleAlternate | Journal of Beijing University of Traditional Chinese Medicine |
| PublicationTitle_FL | Journal of Beijing University of Traditional Chinese Medicine |
| PublicationYear | 2017 |
| Publisher | 北京中医药大学东直门医院 北京100700%广州中医药大学 |
| Publisher_xml | – name: 北京中医药大学东直门医院 北京100700%广州中医药大学 |
| SSID | ssib001103909 ssib008143994 ssj0042135 ssib051370280 ssib017477414 ssib058494076 |
| Score | 2.085908 |
| Snippet | 目的观察新加良附颗粒配合化疗治疗进展期胃癌的临床疗效。方法采用前瞻性随机对照多中心的临床试验方法，并通过中央（网上）随机法将符合Ⅲ／Ⅳ期胃癌患者42例随机分为对照... R273; 目的 观察新加良附颗粒配合化疗治疗进展期胃癌的临床疗效.方法 采用前瞻性随机对照多中心的临床试验方法,并通过中央(网上)随机法将符合Ⅲ/Ⅳ期胃癌患者42例随机分为对... |
| SourceID | wanfang chongqing |
| SourceType | Aggregation Database Publisher |
| StartPage | 593 |
| SubjectTerms | 临床研究 新加良附颗粒 胃癌 进展期胃癌 |
| Title | 新加良附颗粒配合化疗治疗进展期胃癌临床研究 |
| URI | http://lib.cqvip.com/qk/93826A/201707/672833423.html https://d.wanfangdata.com.cn/periodical/bjzyydxxb201707011 |
| Volume | 40 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVEBS databaseName: EBSCOhost Academic Search Ultimate issn: 1006-2157 databaseCode: ABDBF dateStart: 20160101 customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn isFulltext: true dateEnd: 99991231 titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn omitProxy: true ssIdentifier: ssj0042135 providerName: EBSCOhost |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1NaxUxMPQDihdRq1irUrA5PV59u5vPk-z27VKEeqrQ22M_Wzy8-tFC22sVtFQQ0ZaiYPHmSS0iogf_jK-v_RfOZPNeV5GiwhKGyWRmktlNJtlkQshk4cIcICm8OrwrcZ05cVxXDA-750LkLBcyMZfBzN4SM7fZzXk-PzA4Wtm1tLKcTKXrfzxX8j9WBRzYFU_J_oNl-0wBATDYF1KwMKR_ZWMaCqoFDRo05FT51AdAUaWpH9FQU62pYgj4LtWShpIGALiIUUDfxFK6QZUyxaeRFdBAisQCiYOgglE0iKgOkDhwqOZGOpSKjFAPHyTWyCpkNAB6Zoh91A2yQD3NDKBpIKpucU8BaQpCRXoc_KbNQk0U6oxV49Rn1JcGAIyoAMK0A--9RyhNhVQZrUGsL2um-p7hDHmR1c0ANSM1NDLKCjRrvYZUBhVR3zEAYHTN1JdV2r_ZK6erqynlsVHb9ePaCjhAsjo2lKGk7DcgKx09L-91tD4DL2_S_n048rTQZjhCAVN9AbihUJqQsXac-TXgt5Dg8mFgxkEy7OIq0xAZ9oNmEB27ufj_vhJ2TTk4q-z3qzDJBKf--O84dzxZxugpPRTmlhfP9hUaIZNW2-sn6YrhRxaX2gv3wKkyZ9zaRdxeqLhjc2fIaTuPmvDLj-IsGVhfPEdGZu1OkVFy42D7Q2dz7_DJ-6Pdh0dvd7r7z48ePe08e9zZ2u5u7xzsf4P08PurzseXB6_fHG5sdHe3fnz51Pm62d170X33-TyZi8K56Zm6vSykngrXqWdpI-NJwT2dep7IdepkqUpjXTDIjpmMJZdu6hROXqiMZzLzYiWdTKQCAx6BG32BDLWX2vlFMsF57jKpYp6nmjk61Y1GIlXu5iwuGiLPx8h4vxlad8uYMK2-0cbINdswLdtTPGgld9bX1rLV1QQbE8ZYx7l0Io9xcgopy5W-y2Ro-f5KfgV83-Xkqn0VfgILgoTG |
| linkProvider | EBSCOhost |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E6%96%B0%E5%8A%A0%E8%89%AF%E9%99%84%E9%A2%97%E7%B2%92%E9%85%8D%E5%90%88%E5%8C%96%E7%96%97%E6%B2%BB%E7%96%97%E8%BF%9B%E5%B1%95%E6%9C%9F%E8%83%83%E7%99%8C%E4%B8%B4%E5%BA%8A%E7%A0%94%E7%A9%B6&rft.jtitle=%E5%8C%97%E4%BA%AC%E4%B8%AD%E5%8C%BB%E8%8D%AF%E5%A4%A7%E5%AD%A6%E5%AD%A6%E6%8A%A5&rft.au=%E7%8E%8B%E5%A9%A7+%E9%83%AD%E7%8F%8A%E7%8F%8A+%E4%BE%AF%E4%B8%BD+%E9%99%88%E4%BF%A1%E4%B9%89+%E7%94%B0%E5%8A%AD%E4%B8%B9&rft.date=2017&rft.issn=1006-2157&rft.volume=40&rft.issue=7&rft.spage=593&rft.epage=598&rft_id=info:doi/10.3969%2Fj.issn.1006-2157.2017.07.011&rft.externalDocID=672833423 |
| thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F93826A%2F93826A.jpg http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Fbjzyydxxb%2Fbjzyydxxb.jpg |